A Phase 3 Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic Stroke

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 584 participants.

Also called NCT07645586

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 584 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07645586
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07645586. Randomized; quadruple masking; primary purpose treatment. Start 2026-10-01 (anticipated); primary completion 2027-09-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Phase 3 Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic Stroke
Acronym
MASTRE-3
Intervention (Device)
LNM-navigated cTBS
Intervention (Device)
Sham cTBS
Lead sponsor
Beijing Tiantan Hospital (class: other)

Record details

Record id
cardio:ct-nct07645586
Content hash
ce3c120bbd0174cc22827361798463bb16d50195f6257821ec09b969acf9bed7